semaglutide aha select Late Breaking Science: Day 1 Highlights 🫀SELECT Trial: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes ✓: Semaglutide – – Do Sodium-Glucose Cotransporter-2 Inhibitors Influence

Shah S, Henry A, Roselli C, Lin H, Sveinbjornsson G, Fatemifar G, et al

The body adapts to repetitive exercise routines, making them less metabolically demanding over time

Both additives address common patient experiences during GLP-1 therapy: reduced energy from caloric deficit, and the desire to support active fat metabolism

GLP-1s, however, may also exert direct hormonal effects as GLP-1 receptors can be found across the hypothalamus-pituitary-ovarian (HPO) axis and influence gonadotropin release and follicle development

FDA Warnings and Regulatory Actions 2007 Label updated with a warning about acute pancreatitis